These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 15753203)

  • 1. Definition of target antigens for naturally occurring CD4(+) CD25(+) regulatory T cells.
    Nishikawa H; Kato T; Tawara I; Saito K; Ikeda H; Kuribayashi K; Allen PM; Schreiber RD; Sakaguchi S; Old LJ; Shiku H
    J Exp Med; 2005 Mar; 201(5):681-6. PubMed ID: 15753203
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Induction of antigen-specific immunologic tolerance by in vivo and in vitro antigen-specific expansion of naturally arising Foxp3+CD25+CD4+ regulatory T cells.
    Nishimura E; Sakihama T; Setoguchi R; Tanaka K; Sakaguchi S
    Int Immunol; 2004 Aug; 16(8):1189-201. PubMed ID: 15237110
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Crucial role of FOXP3 in the development and function of human CD25+CD4+ regulatory T cells.
    Yagi H; Nomura T; Nakamura K; Yamazaki S; Kitawaki T; Hori S; Maeda M; Onodera M; Uchiyama T; Fujii S; Sakaguchi S
    Int Immunol; 2004 Nov; 16(11):1643-56. PubMed ID: 15466453
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Accelerated chemically induced tumor development mediated by CD4+CD25+ regulatory T cells in wild-type hosts.
    Nishikawa H; Kato T; Tawara I; Takemitsu T; Saito K; Wang L; Ikarashi Y; Wakasugi H; Nakayama T; Taniguchi M; Kuribayashi K; Old LJ; Shiku H
    Proc Natl Acad Sci U S A; 2005 Jun; 102(26):9253-7. PubMed ID: 15961541
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Overlap between molecular markers expressed by naturally occurring CD4+CD25+ regulatory T cells and antigen specific CD4+CD25+ and CD8+CD28- T suppressor cells.
    Scotto L; Naiyer AJ; Galluzzo S; Rossi P; Manavalan JS; Kim-Schulze S; Fang J; Favera RD; Cortesini R; Suciu-Foca N
    Hum Immunol; 2004 Nov; 65(11):1297-306. PubMed ID: 15556680
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Induction of eye-derived tolerance does not depend on naturally occurring CD4+CD25+ T regulatory cells.
    Keino H; Takeuchi M; Kezuka T; Hattori T; Usui M; Taguchi O; Streilein JW; Stein-Streilein J
    Invest Ophthalmol Vis Sci; 2006 Mar; 47(3):1047-55. PubMed ID: 16505040
    [TBL] [Abstract][Full Text] [Related]  

  • 7. TGF-beta1 modulates Foxp3 expression and regulatory activity in distinct CD4+ T cell subsets.
    Pyzik M; Piccirillo CA
    J Leukoc Biol; 2007 Aug; 82(2):335-46. PubMed ID: 17475784
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Foxp3-dependent and -independent molecules specific for CD25+CD4+ natural regulatory T cells revealed by DNA microarray analysis.
    Sugimoto N; Oida T; Hirota K; Nakamura K; Nomura T; Uchiyama T; Sakaguchi S
    Int Immunol; 2006 Aug; 18(8):1197-209. PubMed ID: 16772372
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CD4+ CD25+ [corrected] regulatory T cells render naive CD4+ CD25- T cells anergic and suppressive.
    Qiao M; Thornton AM; Shevach EM
    Immunology; 2007 Apr; 120(4):447-55. PubMed ID: 17244157
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Control of Foxp3+ CD25+CD4+ regulatory cell activation and function by dendritic cells.
    Fehérvári Z; Sakaguchi S
    Int Immunol; 2004 Dec; 16(12):1769-80. PubMed ID: 15520045
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Foxp3 programs the development and function of CD4+CD25+ regulatory T cells.
    Fontenot JD; Gavin MA; Rudensky AY
    Nat Immunol; 2003 Apr; 4(4):330-6. PubMed ID: 12612578
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Foxp3+ CD25- CD4 T cells constitute a reservoir of committed regulatory cells that regain CD25 expression upon homeostatic expansion.
    Zelenay S; Lopes-Carvalho T; Caramalho I; Moraes-Fontes MF; Rebelo M; Demengeot J
    Proc Natl Acad Sci U S A; 2005 Mar; 102(11):4091-6. PubMed ID: 15753306
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of FOXP3 mRNA is not confined to CD4+CD25+ T regulatory cells in humans.
    Morgan ME; van Bilsen JH; Bakker AM; Heemskerk B; Schilham MW; Hartgers FC; Elferink BG; van der Zanden L; de Vries RR; Huizinga TW; Ottenhoff TH; Toes RE
    Hum Immunol; 2005 Jan; 66(1):13-20. PubMed ID: 15620457
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In-vitro generation and characterisation of murine CD4+CD25+ regulatory T cells with indirect allospecificity.
    Tsang J; Jiang S; Tanriver Y; Leung E; Lombardi G; Lechler RI
    Int Immunopharmacol; 2006 Dec; 6(13-14):1883-8. PubMed ID: 17161341
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of a CD4+CD25+ T cell subset committed in vivo to suppress antigen-specific T cell responses without additional stimulation.
    Nolte-'t Hoen EN; Wagenaar-Hilbers JP; Boot EP; Lin CH; Arkesteijn GJ; van Eden W; Taams LS; Wauben MH
    Eur J Immunol; 2004 Nov; 34(11):3016-27. PubMed ID: 15376196
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of alanyl-aminopeptidase on CD4+CD25+ regulatory T-cells enhances expression of FoxP3 and TGF-beta1 and ameliorates acute colitis in mice.
    Bank U; Tadje J; Täger M; Wolke C; Bukowska A; Ittenson A; Reinhold D; Helmuth M; Ansorge S; Shakespeare A; Vieth M; Malfertheiner P; Naumann M; Lendeckel U
    Int J Mol Med; 2007 Oct; 20(4):483-92. PubMed ID: 17786278
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CD25(+)CD4(+) regulatory T cells exert in vitro suppressive activity independent of CTLA-4.
    Kataoka H; Takahashi S; Takase K; Yamasaki S; Yokosuka T; Koike T; Saito T
    Int Immunol; 2005 Apr; 17(4):421-7. PubMed ID: 15724061
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CD4+ CD25+ T cells responding to serologically defined autoantigens suppress antitumor immune responses.
    Nishikawa H; Kato T; Tanida K; Hiasa A; Tawara I; Ikeda H; Ikarashi Y; Wakasugi H; Kronenberg M; Nakayama T; Taniguchi M; Kuribayashi K; Old LJ; Shiku H
    Proc Natl Acad Sci U S A; 2003 Sep; 100(19):10902-6. PubMed ID: 12947044
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of CD8+CD25+Foxp3+ suppressive T cells in colorectal cancer tissue.
    Chaput N; Louafi S; Bardier A; Charlotte F; Vaillant JC; Ménégaux F; Rosenzwajg M; Lemoine F; Klatzmann D; Taieb J
    Gut; 2009 Apr; 58(4):520-9. PubMed ID: 19022917
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of CD4CD25 T cells in autoantibody production in murine lupus.
    Hsu WT; Suen JL; Chiang BL
    Clin Exp Immunol; 2006 Sep; 145(3):513-9. PubMed ID: 16907921
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.